TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32147198

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with mixed nuts (Nuts)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with extra-virgin olive oil (EVOO)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Low-Fat Diet (LFD)
Number of subjects: 155
Study: 35940492

Group type: EXPERIMENTAL
Intervention: Laryngeal tube (LT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endotracheal intubation (ETI)
Number of subjects: 0
Study: 33549600

Group type: EXPERIMENTAL
Intervention: Oral information plus an information pamphlet (Group 1; n = 45)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Oral information alone (Group 2; n = 45)
Number of subjects: 90
Study: 32468955

Group type: EXPERIMENTAL
Intervention: Tucatinib
Number of subjects: 291

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 291
Study: 35787693

Group type: EXPERIMENTAL
Intervention: Solutech (10.0 mg Δ9‐THC, 9.76 mg CBD)
Number of subjects: 32

Group type: COMPARATOR
Intervention: MCT-oil (10.0 mg Δ9‐THC, 9.92 mg CBD)
Number of subjects: 32
Study: 33502237

Group type: EXPERIMENTAL
Intervention: Intense neoadjuvant androgen deprivation therapy followed by radical prostatectomy
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Exceptional pathological response (0-5 mm residual tumor)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Nonresponders (patients without exceptional pathological response)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Testosterone recovery post-treatment
Number of subjects: 117
Study: 33189627

Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 27918

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 27918

Group type: EXPERIMENTAL
Intervention: Lisinopril (in participants with diabetes)
Number of subjects: 27918

Group type: EXPERIMENTAL
Intervention: Lisinopril (in diabetes-free participants)
Number of subjects: 27918

Group type: COMPARATOR
Intervention: Control group (Amlodipine and Doxazosin)
Number of subjects: 27918
Study: 33462940

Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional pharmacological treatment (Essentiale plus Yasmin)
Number of subjects: 20
Study: 32152377

Group type: EXPERIMENTAL
Intervention: Childhood diagnosis (CD) subjects
Number of subjects: 1442

Group type: COMPARATOR
Intervention: Placebo-treated CD subjects
Number of subjects: 1442

Group type: EXPERIMENTAL
Intervention: CD subjects
Number of subjects: 1442
Study: 35715740

Group type: EXPERIMENTAL
Intervention: SDM-assistant
Number of subjects: 252

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 252
Study: 32744056

Group type: EXPERIMENTAL
Intervention: Continuation of aspirin therapy during the perioperative period (33 eyes)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Discontinuation of aspirin therapy for 3 to 7 days before surgery (34 eyes)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group with no antiplatelet/anticoagulant therapy (43 eyes)
Number of subjects: 67
Study: 36280113

Group type: EXPERIMENTAL
Intervention: Dapagliflozin treatment for 5 weeks
Number of subjects: 26
Study: 32562450

Group type: EXPERIMENTAL
Intervention: Smectite at 0.5 g/kg PO per day divided in two to three doses
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group without initial medication
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Smectite group
Number of subjects: 60
Study: 33220069

Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.03% ointment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Triamcinolone acetonide 0.1% cream
Number of subjects: 40
Study: 32570515

Group type: EXPERIMENTAL
Intervention: Patients who received automatic interpretations of laboratory tests
Number of subjects: 3200

Group type: COMPARATOR
Intervention: Patients who did not receive automatic interpretations of laboratory tests
Number of subjects: 3200
Study: 35834790

Group type: EXPERIMENTAL
Intervention: Combination therapy (nivolumab + ipilimumab)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Nivolumab monotherapy
Number of subjects: 79
Study: 34416347

Group type: EXPERIMENTAL
Intervention: SCP-NF (slow cortical potential neurofeedback)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Semi-active control treatment (electromyogram biofeedback)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: SCP-NF
Number of subjects: 103

Group type: COMPARATOR
Intervention: SCP-NF and Semi-active control treatment
Number of subjects: 103
Study: 34586963

Group type: EXPERIMENTAL
Intervention: Total calcium intake (fourth vs. first quartiles in the DHQ cohort)
Number of subjects: 101622

Group type: EXPERIMENTAL
Intervention: Total magnesium intake (fourth vs. first quartiles in the DQX cohort)
Number of subjects: 101622

Group type: EXPERIMENTAL
Intervention: Total phosphorus intake
Number of subjects: 101622
Study: 33712986

Group type: EXPERIMENTAL
Intervention: Sexual risk reduction intervention incorporating alcohol risk reduction content (GPI + GMET)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Information-only control (GINFO)
Number of subjects: 269
Study: 32003294

Group type: COMPARATOR
Intervention: Heavy metal pollution (Pb and Zn) in soil samples from Mitrovica and Obiliqi regions
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: ALA-D enzyme response as a biomarker
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Total chlorophyll content in leaves of onion plants
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: ALA content in leaves of onion plants
Number of subjects: 2
Study: 35708431

Group type: EXPERIMENTAL
Intervention: TAP (triple antibiotic paste)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: UI (ultrasonic activation)
Number of subjects: 180
Study: 33619943

Group type: EXPERIMENTAL
Intervention: Carbon Ankle Seven® (CAFO)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Hinged ankle-foot orthoses (HAFO)
Number of subjects: 10
Study: 32895432

Group type: EXPERIMENTAL
Intervention: Randomised networks preserving community structure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Empirical networks
Number of subjects: 0
Study: 34851731

Group type: EXPERIMENTAL
Intervention: Physical Activity best practices
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Leading a planned PA class more than once a week
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: No screen time during meal or snack
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Not modeling sedentary behavior
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Providing families with information about children's screen time
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Providing children with >60 minutes of outdoor play daily
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Providing children with >45 minutes of adult-led physical activity each day
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Participating in outdoor physical activity with children
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Participating in indoor physical activity with children
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Prompting and praising children for being active
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Talking with children informally about the importance of physical activity
Number of subjects: 127
Study: 33790420

Group type: EXPERIMENTAL
Intervention: Statin use after ADT
Number of subjects: 4428

Group type: EXPERIMENTAL
Intervention: Statin use defined with a one‐year lag
Number of subjects: 4428

Group type: EXPERIMENTAL
Intervention: Statin use before ADT initiation
Number of subjects: 4428

Group type: EXPERIMENTAL
Intervention: Statin use in the first year on ADT
Number of subjects: 4428
Study: 34953603

Group type: COMPARATOR
Intervention: Standard treatment of 77 Gy to the entire prostate in 35 fractions
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: Additional boost to the macroscopic tumor of up to 95 Gy during EBRT
Number of subjects: 571
Study: 32356753

Group type: EXPERIMENTAL
Intervention: Wearable sensors (IMU and GPS data)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Lab assessment of self-selected walking speed
Number of subjects: 31
Study: 34408212

Group type: EXPERIMENTAL
Intervention: Grazing at canopy heights of 12/7 cm, 20/12 cm, 28/17 cm, and 36/22 cm with beef heifers from October 2015 to October 2017.
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Grazing intensity (various canopy heights).
Number of subjects: 87
Study: 32730797

Group type: COMPARATOR
Intervention: VOL + US
Number of subjects: 51

Group type: COMPARATOR
Intervention: VOL
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: VOL and VOL + US
Number of subjects: 51
Study: 34099307

Group type: EXPERIMENTAL
Intervention: GENE arm (pharmacogenetic testing results available at baseline, n = 84)
Number of subjects: 176

Group type: COMPARATOR
Intervention: TAU arm (treatment-as-usual, testing results not available until 8-week visit, n = 92)
Number of subjects: 176
Study: 34330539

Group type: EXPERIMENTAL
Intervention: Advanced Training in Laparoscopic Suturing
Number of subjects: 39

Group type: COMPARATOR
Intervention: Fundamentals of Laparoscopic Surgery
Number of subjects: 39
Study: 35907262

Group type: EXPERIMENTAL
Intervention: Active rTMS (10 Hz)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Active WMT
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Active rTMS + Active WMT
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham WMT
Number of subjects: 43
Study: 34616363

Group type: EXPERIMENTAL
Intervention: DROI-FET
Number of subjects: 307

Group type: COMPARATOR
Intervention: mNC-FET
Number of subjects: 307
Study: 34469646

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil + glucocorticoid
Number of subjects: 120

Group type: COMPARATOR
Intervention: Glucocorticoid only (standard care)
Number of subjects: 120
Study: 32842225

Group type: EXPERIMENTAL
Intervention: H-UPPP combined with Eco-TBR
Number of subjects: 60

Group type: COMPARATOR
Intervention: Simple H-UPPP (Control)
Number of subjects: 60
Study: 35961356

Group type: EXPERIMENTAL
Intervention: Typhoid conjugate vaccine (TCV)
Number of subjects: 631

Group type: COMPARATOR
Intervention: Meningococcal serogroup A conjugate vaccine (MCV-A)
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: TCV
Number of subjects: 631

Group type: COMPARATOR
Intervention: MCV-A
Number of subjects: 631
Study: 32166551

Group type: EXPERIMENTAL
Intervention: Endoscopic resection (ER)
Number of subjects: 391

Group type: COMPARATOR
Intervention: Surgical resection (SR)
Number of subjects: 391

Group type: COMPARATOR
Intervention: Laparoscopic surgery (hypothetical comparison)
Number of subjects: 391
Study: 35285531

Group type: COMPARATOR
Intervention: paper CARAT
Number of subjects: 31

Group type: COMPARATOR
Intervention: online CARAT
Number of subjects: 31

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 31
Study: 32333539

Group type: EXPERIMENTAL
Intervention: Long-snake moxibustion
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 90

Group type: COMPARATOR
Intervention: Medication (Diclofenac Sodium and Mecobalamine)
Number of subjects: 90
Study: 35551290

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg d−1 with closed-loop therapy
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg d−1 with sensor-augmented pump (SAP) therapy
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Closed-loop therapy plus empagliflozin
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo with closed-loop therapy
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo with SAP therapy
Number of subjects: 27
Study: 33914770

Group type: EXPERIMENTAL
Intervention: Transition readiness assessment
Number of subjects: 786

Group type: EXPERIMENTAL
Intervention: Trusting peer educators for HIV treatment
Number of subjects: 786

Group type: EXPERIMENTAL
Intervention: Receiving counselling on transition to adult services
Number of subjects: 786

Group type: EXPERIMENTAL
Intervention: Visiting an adult clinic to prepare for transition
Number of subjects: 786

Group type: EXPERIMENTAL
Intervention: Satisfaction with the transition process
Number of subjects: 786
Study: 36027483

Group type: EXPERIMENTAL
Intervention: Erlotinib
Number of subjects: 102

Group type: COMPARATOR
Intervention: Vinorelbine/Cisplatin (Chemotherapy)
Number of subjects: 102
Study: 33579322

Group type: EXPERIMENTAL
Intervention: 5-domain NPCCSS
Number of subjects: 49
Study: 33964483

Group type: EXPERIMENTAL
Intervention: Short wavelength light for 8 weeks
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Long wavelength light for 8 weeks
Number of subjects: 3

Group type: COMPARATOR
Intervention: White light for 8 weeks
Number of subjects: 3
Study: 33105928

Group type: EXPERIMENTAL
Intervention: Yimitasvir phosphate capsules with sofosbuvir tablets
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Yimitasvir phosphate capsules with omeprazole magnesium enteric-coated tablets
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Yimitasvir phosphate capsules with rosuvastatin calcium tablets
Number of subjects: 84
Study: 35294067

Group type: EXPERIMENTAL
Intervention: Insulin resistance (IR) defined by HOMA-IR >2.5
Number of subjects: 84

Group type: COMPARATOR
Intervention: Non-insulin resistance (non-IR)
Number of subjects: 84
Study: 32557001

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser therapy with 50 units of BTX-A solution applied topically post-operatively
Number of subjects: 3

Group type: COMPARATOR
Intervention: Untreated control (other palm)
Number of subjects: 3
Study: 32942294

Group type: EXPERIMENTAL
Intervention: Implemental mindset
Number of subjects: 64

Group type: COMPARATOR
Intervention: Deliberative mindset
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both mindsets
Number of subjects: 64
Study: 35805348

Group type: EXPERIMENTAL
Intervention: Group EMDR intervention for three weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 27
Study: 86263812

Group type: EXPERIMENTAL
Intervention: Branched chain amino acids (0.25 g/kg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Casein (0.25 g/kg/day)
Number of subjects: 22
Study: 35908387

Group type: EXPERIMENTAL
Intervention: 10% body mass (Group 2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 20% body mass (Group 3)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No load (Group 1)
Number of subjects: 30
Study: 34639688

Group type: EXPERIMENTAL
Intervention: Self-sampling devices (FLOQSwabs, Evalyn Brush, Colli-Pee FV-5000)
Number of subjects: 65
Study: 35848042

Group type: EXPERIMENTAL
Intervention: Multimodal stimulations (MMS) for 30 minutes per session, five days per week until discharge
Number of subjects: 60

Group type: COMPARATOR
Intervention: Regular lifesaving care from the NICU
Number of subjects: 60
Study: 33519155

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention
Number of subjects: 888
Study: 33012658

Group type: EXPERIMENTAL
Intervention: Oil-based contrast
Number of subjects: 1107

Group type: COMPARATOR
Intervention: Water-based contrast
Number of subjects: 1107
Study: 34814156

Group type: EXPERIMENTAL
Intervention: cPFM‐T in supine position (SUG)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: cPFM‐T in sitting position (SIG)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (COG)
Number of subjects: 55
Study: 34314235

Group type: EXPERIMENTAL
Intervention: Arm-cycle ergometer training (ACET)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Body-weight-supported treadmill training (BWSTT)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 46
Study: 32317241

Group type: EXPERIMENTAL
Intervention: Machine learning-based treatment planning system (PIPA system)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional, manual treatment planning technique
Number of subjects: 41
Study: 35474582

Group type: EXPERIMENTAL
Intervention: Sublingual 300 IR HDM tablets
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 100
Study: 33055145

Group type: EXPERIMENTAL
Intervention: Alteplase (thrombolysis)
Number of subjects: 2916
Study: 36101998

Group type: EXPERIMENTAL
Intervention: 12-week community-based exercise programme (FitSkills)
Number of subjects: 20
Study: 34035435

Group type: EXPERIMENTAL
Intervention: TARGIT‐IORT
Number of subjects: 2298

Group type: COMPARATOR
Intervention: TARGIT‐IORT plus EBRT
Number of subjects: 2298

Group type: COMPARATOR
Intervention: EBRT
Number of subjects: 2298
Study: 33444385

Group type: EXPERIMENTAL
Intervention: Bayesian prediction models with elicited expert opinion
Number of subjects: 118

Group type: COMPARATOR
Intervention: Original frequentist approach
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Bayesian models with elicited expert opinion
Number of subjects: 118
Study: 34637064

Group type: EXPERIMENTAL
Intervention: Breastfeeding support intervention
Number of subjects: 13
Study: 33617653

Group type: EXPERIMENTAL
Intervention: Polyethersulfone (PES) membranes
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ethylene-vinyl alcohol copolymer (EVAL) membranes
Number of subjects: 8

Group type: COMPARATOR
Intervention: EVAL membranes
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: PES membranes
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both membrane types
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both membrane sets
Number of subjects: 8
Study: 32202203

Group type: EXPERIMENTAL
Intervention: Treadmill training augmented by virtual reality (TT + VR)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Usual treadmill walking (TT)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Treadmill training (TT + VR and TT)
Number of subjects: 121
Study: 36134707

Group type: EXPERIMENTAL
Intervention: Prediction model developed using clinical and drug-related variables from training data set.
Number of subjects: 1446
Study: 34283733

Group type: EXPERIMENTAL
Intervention: Peer teaching series (RxReady)
Number of subjects: 98
Study: 32700954

Group type: EXPERIMENTAL
Intervention: Behavioral Activation and Motivational Interviewing intervention (5 sessions)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Pre-post assessment of depression symptoms and family-related outcomes
Number of subjects: 9
Study: 35235635

Group type: EXPERIMENTAL
Intervention: Liquid PRF
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control
Number of subjects: 15
Study: 33795569

Group type: EXPERIMENTAL
Intervention: Double-pass pulsed-dye laser (DPL) with long pulse duration (20 m/s) followed by short pulse duration (1.5 m/s)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Single-pass pulsed-dye laser (SPL) at 1.5 m/s
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Double-pass pulsed-dye laser (DPL)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Single-pass pulsed-dye laser (SPL)
Number of subjects: 24
Study: 32941336

Group type: EXPERIMENTAL
Intervention: Pneumatonometry
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Transpalpebral tonometry
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Instrumentation used for IOP measurement
Number of subjects: 20
Study: 35657826

Group type: EXPERIMENTAL
Intervention: lenacapavir as PrEP
Number of subjects: 0
Study: 34769642

Group type: EXPERIMENTAL
Intervention: Posters as a teaching tool
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Pre-practice hand contamination
Number of subjects: 293
Study: 32519599

Group type: EXPERIMENTAL
Intervention: Regular low-dose sustained-release morphine (8-32 mg/24 h)
Number of subjects: 22
Study: 35294582

Group type: EXPERIMENTAL
Intervention: Ureteral stent crossing the bladder midline
Number of subjects: 113

Group type: COMPARATOR
Intervention: Ureteral stent not crossing the bladder midline
Number of subjects: 113
Study: 32009828

Group type: EXPERIMENTAL
Intervention: Tailor‐made standard rehabilitation (TMSR) plus immersive VR device
Number of subjects: 262

Group type: COMPARATOR
Intervention: Tailor‐made standard rehabilitation (TMSR)
Number of subjects: 262
Study: 36151557

Group type: EXPERIMENTAL
Intervention: Canagliflozin initiated based on HbA1c ≥ 7.5% (n=2809)
Number of subjects: 3713

Group type: EXPERIMENTAL
Intervention: Canagliflozin initiated based on clinical characteristics
Number of subjects: 3713

Group type: EXPERIMENTAL
Intervention: Canagliflozin initiated based on combined clinical characteristics and novel biomarkers
Number of subjects: 3713

Group type: COMPARATOR
Intervention: Canagliflozin initiated based on HbA1c or UACR alone
Number of subjects: 3713
Study: 34020263

Group type: EXPERIMENTAL
Intervention: Probiotic fermented dairy food (N = 79)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Placebo fermented dairy food (N = 85)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Diet-as-usual (N = 98)
Number of subjects: 262
Study: 35275529

Group type: EXPERIMENTAL
Intervention: DHP1401 500 mg
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: DHP1401 1000 mg
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: DHP1401 500 mg and Donepezil 5 mg
Number of subjects: 180
Study: 32691198

Group type: EXPERIMENTAL
Intervention: Casino players
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Sports bettors
Number of subjects: 10000
Study: 35457349

Group type: EXPERIMENTAL
Intervention: Personalized education on breast cancer using a mobile medical app based on algorithms with conditions
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group (no personalized education)
Number of subjects: 500
Study: 33211076

Group type: EXPERIMENTAL
Intervention: SB11
Number of subjects: 705

Group type: COMPARATOR
Intervention: Ranibizumab
Number of subjects: 705
Study: 33556589

Group type: EXPERIMENTAL
Intervention: web-based stepped collaborative care intervention
Number of subjects: 450

Group type: COMPARATOR
Intervention: screening and referral arm
Number of subjects: 450
Study: 32164728

Group type: EXPERIMENTAL
Intervention: Maternity waiting homes (MWHs) intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation effectiveness of MWH model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Routine health facility assessment
Number of subjects: 0
Study: 35449384

Group type: EXPERIMENTAL
Intervention: Pain provocation after the first 10 minutes of upright position
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard tilt table test with no provocation for further 30 minutes
Number of subjects: 101
Study: 33389796

Group type: EXPERIMENTAL
Intervention: Intralesional combined digoxin and furosemide
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intralesional normal saline
Number of subjects: 40